Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Oct;46(1):120–129.

The role of carbohydrate in the structure and function of nephritic factor.

D M Scott, N Amos, S R Bartolotti
PMCID: PMC1536321  PMID: 6802534

Abstract

Six nephritic factors (NeFs) were purified from the IgG fraction of sera of patients with PLD and/or MPGN by elution from EA C43bBb. All had at least one abnormal H chain component when examined by PAGE-SDS and two additionally had a large L chain. Four different H chains were found. Their apparent molecular weights and the frequency with which they occurred were: 65,000 (one NeF), 61,500 (four NeFs), 57,000 (two NeFs) and 55,000 (one NeF) compared with 53,500 daltons for normal H chain. The molecular weight of the large L chains was 26,500 daltons (cf. 23,500 for normal L chain). Both the NeF activity and the large components were located in the F(ab')2 fragment of the molecule and after reduction the large component was found in the Fd fragment of the H chain. Neuraminidase treatment of purified NeF caused a 1-2% decrease in apparent molecular weight of the large H chain on PAGE-SDS. Mild periodate oxidation, sufficient to cause primarily loss of carbohydrate, caused a marked loss of activity. Reduction and alkylation of NeF under neutral conditions caused only a small loss of activity but after acid dissociation the H and L chains were completely inactive.

Full text

PDF
120

Images in this article

124Fig. 1
on p.124
124Fig. 2
on p.124
125Fig. 3
on p.125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos N., Sissons J. G., Girard J. F., Lachmann P. J., Peters D. K. The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro. Clin Exp Immunol. 1976 Jun;24(3):474–482. [PMC free article] [PubMed] [Google Scholar]
  2. Andersen B. R., Abele D. C., Vannier W. E. Effects of mild eriodate oxidation on antibodies. J Immunol. 1966 Dec;97(6):913–924. [PubMed] [Google Scholar]
  3. Buchowicz I., Zakrzewski K. Carbohydrate oxidation and antibody function in equine anti-diphtheria immunoglobulin T. Immunochemistry. 1975 Oct;12(10):795–800. doi: 10.1016/0019-2791(75)90142-1. [DOI] [PubMed] [Google Scholar]
  4. Capel P. J., Groeneboer O., Grosveld G., Pondman K. W. The binding of activated C3 to polysaccharides and immunoglobulins. J Immunol. 1978 Dec;121(6):2566–2572. [PubMed] [Google Scholar]
  5. Czop J., Nussenzweig V. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med. 1976 Mar 1;143(3):615–630. doi: 10.1084/jem.143.3.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daha M. R., Austen K. F., Fearon D. T. The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function. J Immunol. 1977 Sep;119(3):812–817. [PubMed] [Google Scholar]
  7. Daha M. R., Fearon D. T., Austen K. F. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol. 1976 Jan;116(1):1–7. [PubMed] [Google Scholar]
  8. Daha M. R., van Es L. A. Further evidence for the antibody nature of C3 nephritic factor (C3NeF). J Immunol. 1979 Aug;123(2):755–758. [PubMed] [Google Scholar]
  9. Davis A. E., 3rd, Arnaout M. A., Alper C. A., Rosen F. S. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? N Engl J Med. 1977 Jul 21;297(3):144–145. doi: 10.1056/NEJM197707212970306. [DOI] [PubMed] [Google Scholar]
  10. FLEISCHMAN J. B., PAIN R. H., PORTER R. R. Reduction of gamma-globulins. Arch Biochem Biophys. 1962 Sep;Suppl 1:174–180. [PubMed] [Google Scholar]
  11. Harrison R. A., Lachmann P. J. An improved purification procedure for the third component of complement and beta 1H globulin from human serum. Mol Immunol. 1979 Oct;16(10):767–776. doi: 10.1016/0161-5890(79)90154-8. [DOI] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Laskey R. A., Mills A. D. Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975 Aug 15;56(2):335–341. doi: 10.1111/j.1432-1033.1975.tb02238.x. [DOI] [PubMed] [Google Scholar]
  14. Law S. K., Levine R. P. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701–2705. doi: 10.1073/pnas.74.7.2701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Macanovic M., Lachmann P. J. Conglutinin binding polyethylene glycol precipitation assay for immune complexes. Clin Exp Immunol. 1979 Nov;38(2):274–283. [PMC free article] [PubMed] [Google Scholar]
  16. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  17. Schreiber R. D., Götze O., Müller-Eberhard H. J. Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway. Scand J Immunol. 1976;5(6-7):705–713. doi: 10.1111/j.1365-3083.1976.tb03020.x. [DOI] [PubMed] [Google Scholar]
  18. Scott D. M., Amos N., Sissons J. G., Lachmann P. J., Peters D. K. The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol. 1978 Apr;32(1):12–24. [PMC free article] [PubMed] [Google Scholar]
  19. Sissons J. G., West R. J., Fallows J., Williams D. G., Boucher B. J., Amos N., Peters D. K. The complement abnormalities of lipodystrophy. N Engl J Med. 1976 Feb 26;294(9):461–465. doi: 10.1056/NEJM197602262940902. [DOI] [PubMed] [Google Scholar]
  20. Sobel A. T., Cooper N. R., Schreiber R. D. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase. J Immunol. 1979 Jan;122(1):34–38. [PubMed] [Google Scholar]
  21. Sox H. C., Jr, Hood L. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc Natl Acad Sci U S A. 1970 Jul;66(3):975–982. doi: 10.1073/pnas.66.3.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Spiegelberg H. L., Abel C. A., Fishkin B. G., Grey H. M. Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins. Biochemistry. 1970 Oct 13;9(21):4217–4223. doi: 10.1021/bi00823a025. [DOI] [PubMed] [Google Scholar]
  23. Spitzer R. E., Vallota E. H., Forristal J., Sudora E., Stitzel A., Davis N. C., West C. D. Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969 Apr 25;164(3878):436–437. doi: 10.1126/science.164.3878.436. [DOI] [PubMed] [Google Scholar]
  24. Tarentino A. L., Plummer T. H., Jr, Maley F. The release of intact oligosaccharides from specific glycoproteins by endo-beta-N-acetylglucosaminidase H. J Biol Chem. 1974 Feb 10;249(3):818–824. [PubMed] [Google Scholar]
  25. Thompson R. A. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis. Immunology. 1972 Jan;22(1):147–158. [PMC free article] [PubMed] [Google Scholar]
  26. Tomana M., Niedermeier W., Skvaril F. Carbohydrate composition and complement fixation of human monoclonal IgG. Immunochemistry. 1974 Jul;11(7):337–339. doi: 10.1016/0019-2791(74)90185-2. [DOI] [PubMed] [Google Scholar]
  27. Vallota E. H., Forristal J., Spitzer R. E., Davis N. C., West C. D. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum. J Exp Med. 1970 Jun 1;131(6):1306–1324. doi: 10.1084/jem.131.6.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weiler J. M., Daha M. R., Austen K. F., Fearon D. T. Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268–3272. doi: 10.1073/pnas.73.9.3268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Whaley K., Ruddy S. Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med. 1976 Nov 2;144(5):1147–1163. doi: 10.1084/jem.144.5.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Williams D. G., Lachmann P. J., Charlesworth J. A., Peters D. K. Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet. 1973 Mar 3;1(7801):447–449. doi: 10.1016/s0140-6736(73)91877-1. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES